← Open Payments lookup

KIMBERLY SALSMAN: Open Payments

NPI 1295407047 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$911 in 43 payments from 15 companies in 2025. Trend: 2023 $832 · 2024 $764 · 2025 $911

Food & beverage: $911
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$190
Novo Nordisk Inc5$165
Lilly USA, LLC10$136
GlaxoSmithKline, LLC.5$94
Bayer Healthcare Pharmaceuticals Inc.5$93
Abbott Laboratories2$39
ABBVIE INC.2$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$35
GENZYME CORPORATION1$23
Verona Pharma, Inc.1$20

Products named: BREZTRI, Ozempic, MOUNJARO, TRELEGY ELLIPTA, Kerendia, FREESTYLE LIBRE, XIFAXAN, KISUNLA.

Industry payments across LA — which companies pay providers there.